The PRAME-AS knockout cells showed a decrease in migration, proliferation, stemness, and viability. by Zahra Hosseininia (22265113)

GSK343 decreased tumor stemness. by Laura V. Bownes (10276762)

“…Treatment with GSK343 significantly decreased tumorsphere formation by both the COA3 (A) and COA6 (B) cells, representing a decrease in stem cell-like phenotype. …”

A decrease in CD44+ cells in response to hypoxia. by Daniel V. Brown (3797809)

CD47 expression is decreased in hematopoietic progenitor cells in patients with myelofibrosis by A. Nonino (6072632)

“…We compared CD47 expression in hematopoietic stem and progenitor cells of patients with MF and controls and found it to be decreased in progenitors of MF. …”

MSCs decrease lung inflammation. by Konrad Urbanek (439073)

Ketamine decreases NSC viability in a dose-dependent manner. by Shiva Mansouri (2838086)

Exogenous FGF4 decreases osteogenic differentiation of mESCs. by Sung-Ho Kook (445098)

Subjects:

The ratio of standard deviation to mean dose (SD/mean) decreases with neuronal dose. by Murat Alp (781371)

Transplantation of Exendin-4 pretreated ADSCs decrease apoptosis, fibrosis, and promote angiogenesis. by Jianfeng Liu (122580)

siRNA-mediated APP-BP1 knock-down significantly decreases BrdU-incorporated fetal neural stem cells. by Yuyoung Joo (236048)

hESCs-CM decreased cancer cells growth. by Shufeng Zhou (398572)

Subjects:

Necdin deficiency decreases <i>p16</i> expression and increases <i>Cdk1</i> expression in primary NPCs. by Ryohei Minamide (505053)

Subjects:

Running increased neural stem cell proliferation in the dentate gyrus, but did not decrease inflammation. by Kaja Falkenhain (9317016)

Effect of CXCL8 (200 pg/ml), CCL20 (500 pg/ml), CXCL8-CM, and CCL20-CM on osteoclast formation. by Janak L. Pathak (759122)

Caspase-1 activity in cell-extract decreases over time. by Obada R. Shamaa (830382)

Naloxone decreases the number of apoptotic cells induced by morphine but does not affect their profile. by Dafna Willner (605895)

Subjects:

Cell adhesion to fibronectin is decreased with 50 µM 4N1K treatment. by Pascal Leclair (566971)

Loss of Prox1a decreases PR production at 120 hours post-ablation. by Kellie Veen (17343374)

Simvastatin decreases eNOS expression. by Mohammed Sabri (355717)

Resveratrol decreases PKM2 expression. by Mohd Askandar Iqbal (324124)

“…<p>Resveratrol treatment decreases PKM2 mRNA in (A), HeLa; (B), HepG2 and (C), MCF-7; by approximately two-folds. β-actin was taken as endogenous control and normalized to PKM2 mRNA. …”